Comparison of efficacy of low-carbohydrate and low-fat diet education programs in non-alcoholic fatty liver disease: A randomized controlled study

被引:27
|
作者
Jang, Eun Chul [1 ]
Jun, Dae Won [2 ]
Lee, Seung Min [3 ]
Cho, Yong kyun [4 ]
Ahn, Sang Bong [5 ]
机构
[1] Soonchunhyang Univ, Dept Occupat & Environm Med, Cheonan, South Korea
[2] Hanyang Univ, Dept Internal Med, Seoul, South Korea
[3] Sungshin Womens Univ, Dept Food & Nutr, 147 Mia Dong, Seoul 142100, South Korea
[4] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Seoul, South Korea
[5] Eulji Univ, Dept Internal Med, Seoul, South Korea
关键词
carbohydrate; fat; non-alcoholic fatty liver disease; METABOLIC SYNDROME; ADULTS; RISK;
D O I
10.1111/hepr.12918
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: Composition of macronutrients is important in non-alcoholic fatty liver disease (NAFLD). Diet education programs that mainly emphasize reducing fat consumption have been used for NAFLD patients. We compared the efficacy of conventional low-fat diet education with low-carbohydrate diet education in Korean NAFLD patients. Methods: One hundred and six NAFLD patients were randomly allocated to low-fat diet education or low-carbohydrate education groups for 8weeks. Liver chemistry, liver/spleen ratio, and visceral fat using abdominal tomography were measured. Results: Intrahepatic fat accumulation decreased significantly in the low-carbohydrate group compared to low-fat group (liver/spleen 0.85 vs. 0.92, P<0.05). Normalization of ALT activity at week 8 was 38.5% for the low-carbohydrate and 16.7% for the low-fat group (P=0.016). Not only liver enzyme, but also low density lipoprotein cholesterol and blood pressure levels significantly decreased in the low-carbohydrate group. Total energy intake was also further decreased in the low-carbohydrate group compared to the low-fat group. Although body weight changes were not different between the two groups, the carbohydrate group had a lower total abdominal fat amount. Conclusions: A low-carbohydrate diet program is more realistic and effective in reducing total energy intake and hepatic fat content in Korean NAFLD patients.
引用
收藏
页码:E22 / E29
页数:8
相关论文
共 50 条
  • [21] A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals
    Koneru, Kavya
    Bhatt, Varsha
    Kakrani, Arjun
    Edara, Manaswini
    Reddy, Vuluvala T.
    Jawade, Pranav Gopal
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (08) : 4368 - 4374
  • [22] Characterization of fat metabolism in the fatty liver caused by a high-fat, low-carbohydrate diet: A study under equal energy conditions
    Kurosaka, Yuka
    Shiroya, Yoko
    Yamauchi, Hideki
    Kitamura, Hiromi
    Minato, Kumiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 487 (01) : 41 - 46
  • [23] Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
    Varkaneh, Hamed Kord
    Sahlabadi, Ammar Salehi
    Gaman, Mihnea-Alexandru
    Rajabnia, Mohsen
    Macit-Celebi, Melahat Sedanur
    Santos, Heitor O.
    Hekmatdoost, Azita
    FRONTIERS IN NUTRITION, 2022, 9
  • [24] Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial
    George, Elena S.
    Reddy, Anjana
    Nicoll, Amanda J.
    Ryan, Marno C.
    Itsiopoulos, Catherine
    Abbott, Gavin
    Johnson, Nathan A.
    Sood, Siddharth
    Roberts, Stuart K.
    Tierney, Audrey C.
    LIVER INTERNATIONAL, 2022, 42 (06) : 1308 - 1322
  • [25] Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
    Charlot, Anouk
    Bringolf, Anthony
    Mallard, Joris
    Charles, Anne-Laure
    Niederhoffer, Nathalie
    Duteil, Delphine
    Pagano, Allan F.
    Geny, Bernard
    Zoll, Joffrey
    FRONTIERS IN NUTRITION, 2024, 11
  • [26] Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
    Camila Ribeiro de Avelar
    Beatriz Vieira Coelho Nunes
    Betina da Silva Sassaki
    Mariana dos Santos Vasconcelos
    Lucivalda Pereira Magalhães de Oliveira
    André Castro Lyra
    Allain Amador Bueno
    Rosângela Passos de Jesus
    Trials, 24
  • [27] The efficacy of silymarin in decreasing transaminase activities in non-alcoholic fatty liver disease: A randomized controlled clinical trial
    Hajaghamohammadi, Ali-Akbar
    Ziaee, Amir
    Rafiei, Ramin
    HEPATITIS MONTHLY, 2008, 8 (03) : 191 - 195
  • [28] Efficacy of silymarin in patients with non-alcoholic fatty liver disease - the Siliver trial: a study protocol for a randomized controlled clinical trial
    de Avelar, Camila Ribeiro
    Nunes, Beatriz Vieira Coelho
    Sassaki, Betina da Silva
    Vasconcelos, Mariana dos Santos
    de Oliveira, Lucivalda Pereira Magalhaes
    Lyra, Andre Castro
    Bueno, Allain Amador
    de Jesus, Rosangela Passos
    TRIALS, 2023, 24 (01)
  • [29] Establishment of a non-alcoholic fatty liver disease model by high fat diet in adult zebrafish
    Li, Xiang
    Zhou, Lei
    Zheng, Yuying
    He, Taiping
    Guo, Honghui
    Li, Jiangbin
    Zhang, Jingjing
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2024, 7 (06) : 904 - 913
  • [30] The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial
    Yurtdas, Gamze
    Akbulut, Gamze
    Baran, Masallah
    Yilmaz, Canan
    PEDIATRIC OBESITY, 2022, 17 (04):